Dolenio for osteoarthritis

Dolenio is a new glucosamine product licensed for the symptomatic treatment of mild to moderate osteoarthritis of the knee.

Dolenio is a once daily tablet formulation of glucosamine sulphate.

Treatment may take several weeks or longer to provide relief of symptoms; if after 2 to 3 months no symptom relief is observed then continued treatment with glucosamine should be reviewed.

View Dolenio drug record

Further information: Blue Bio Pharmaceuticals

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in